Q32 Bio Inc (QTTB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$11.99-6.33%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · QTTB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | — | 53.7 | — | 1.2 | 3.2 | 34.0 | 2.7 | 1.7 | 3.7 |
| Total Revenues | — | 53.7 | — | — | — | — | — | — | 3.7 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 14.3 | 19.2 | 48.1 | 31.7 | 98.4 | 93.1 | 100.4 | 89.4 | 47.9 |
| Other Operating Expenses, Total | — | 0.4 | 1.5 | — | — | — | — | — | — |
| Operating Income | 21.5 | 16.9 | (66.1) | (48.3) | (133.3) | (95.9) | (130.3) | (109.9) | (59.9) |
| Earnings from Continuing Operations | |||||||||
| Interest & Investment Income | — | — | — | 5.6 | 3.2 | 0.2 | 1.6 | 6.0 | 4.3 |
| Other Non-Operating Income / Expenses | 12.3 | 12.9 | 20.0 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | 29.8 | (46.1) | (87.1) | 1.2 | — | — | — | — |
| Income Tax Expense | — | — | 0.0 | 0.3 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||
| Net Income | 33.8 | 29.8 | (47.7) | (53.7) | (5.0) | (95.8) | (128.7) | (103.9) | (55.6) |
| Per Share | |||||||||
| Basic EPS | 1.66 | 2.42 | (5.12) | (153.96) | (0.09) | — | — | — | — |
| Diluted EPS | 1.66 | 2.42 | (6.58) | (153.96) | (0.09) | — | — | — | — |
| Basic Weighted Avg Shares | 20.3 | 12.3 | 9.3 | 0.3 | 57.4 | — | — | — | — |
| Diluted Weighted Avg Shares | 20.3 | 12.3 | 9.7 | 0.3 | 57.4 | — | — | — | — |
| Supplemental | |||||||||
| EBIT | 21.5 | 16.9 | (66.1) | (48.3) | (133.3) | (95.9) | (130.3) | (109.9) | (59.9) |
| Effective Tax Rate | — | — | — | -0.4% | 59.7% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.